Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin
- 24 June 2015
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 116 (6), 904-912
- https://doi.org/10.1016/j.amjcard.2015.06.016
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke
This publication has 23 references indexed in Scilit:
- The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial FibrillationJournal of the American College of Cardiology, 2013
- Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus RhythmCirculation: Heart Failure, 2013
- Warfarin and Aspirin in Patients with Heart Failure and Sinus RhythmThe New England Journal of Medicine, 2012
- Warfarin in Heart FailureThe New England Journal of Medicine, 2012
- Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY TrialAnnals of Internal Medicine, 2011
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyJournal of the American College of Cardiology, 2011
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on ThrombosisEP Europace, 2011
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) ScoreJournal of the American College of Cardiology, 2011
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010